Hyperion Therapeutics Inc (NASDAQ:HPTX)

45.98
Delayed Data
As of Mar 30
 +3.24 / +7.58%
Today’s Change
20.23
Today|||52-Week Range
46.96
+91.58%
Year-to-Date

Stock Price Forecast

The 8 analysts offering 12-month price forecasts for Hyperion Therapeutics Inc have a median target of 39.00, with a high estimate of 52.00 and a low estimate of 35.00. The median estimate represents a -15.18% decrease from the last price of 45.98.

Analyst Recommendations

The current consensus among 8 polled investment analysts is to Buy stock in Hyperion Therapeutics Inc. This rating has held steady since March, when it was unchanged from a Buy rating.Move your mouse over past
months for detail

 
 
 
 
 
 
 
 

Earnings and Sales Forecasts

Current Quarter

Earnings per Share
$0.22
Sales
$29.0M
Reporting Date
May 07

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly -30.80%
 
 
 
 
 
 
Growthannually 336.69%
 
 
 
 
 
 

Sales

Growthquarterly -5.92%
 
 
 
 
 
 
Growthannually 10.75%
 
 
 
 
 
 
Key to the earnings and sales forecast charts.

To view my watchlist

Not a member yet?

Sign up now for a free account